Literature DB >> 8131451

Bronchial hyperresponsiveness and toluene diisocyanate. Long-term change in sensitized asthmatic subjects.

P L Paggiaro1, B Vagaggini, F L Dente, E Bacci, L Bancalari, M Carrara, A Di Franco, D Giannini, C Giuntini.   

Abstract

Long-term change in nonspecific and specific bronchial hyperresponsiveness was studied in 16 subjects with asthma induced by toluene diisocyanate (TDI). A significant positive correlation between months of follow-up and provocative dose inducing a 20 percent fall in FEV1 (PD20FEV1) methacholine was observed in 5 of 16 subjects. In 4 of these 5 subjects, a PD20FEV1 > 1 mg of methacholine was observed 30 to 48 months after the end of TDI exposure. In most subjects, nonspecific bronchial hyperresponsiveness did not change. Nine of 16 subjects became nonresponsive to TDI at follow-up examination, but only 3 of these showed a significant increase in PD20FEV1 methacholine. Seven subjects were still responsive to TDI. Recovery from TDI-induced asthma can occur and only after long-term work cessation. Nonspecific bronchial hyperresponsiveness to methacholine can persist even in the absence of bronchial hyperresponsiveness to TDI, suggesting permanent chronic damage to mechanisms controlling airway tone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131451     DOI: 10.1378/chest.103.4.1123

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges.

Authors:  O Vandenplas; J P Delwiche; J Jamart; R Van de Weyer
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

Review 2.  Outcome of occupational asthma after cessation of exposure: a systematic review.

Authors:  George Rachiotis; Rashna Savani; Andrew Brant; Stephanie J MacNeill; Anthony Newman Taylor; Paul Cullinan
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

Review 3.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

4.  Outcome determinants for isocyanate induced occupational asthma among compensation claimants.

Authors:  S M Tarlo; D Banks; G Liss; I Broder
Journal:  Occup Environ Med       Date:  1997-10       Impact factor: 4.402

5.  Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure.

Authors:  G Pisati; A Baruffini; F Bernabeo; S Cerri; A Mangili
Journal:  Int Arch Occup Environ Health       Date:  2006-09-07       Impact factor: 3.015

Review 6.  Respiratory and other hazards of isocyanates.

Authors:  X Baur; W Marek; J Ammon; A B Czuppon; B Marczynski; M Raulf-Heimsoth; H Roemmelt; G Fruhmann
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

7.  Asthma-like symptoms, atopy, and bronchial responsiveness in furniture workers.

Authors:  D Talini; A Monteverdi; A Benvenuti; M Petrozzino; F Di Pede; M Lemmi; A Carletti; P Macchioni; N Serretti; G Viegi; P Paggiaro
Journal:  Occup Environ Med       Date:  1998-11       Impact factor: 4.402

8.  Comparison between Airway Responses to High versus Low Molecular Weight Compounds in Occupational Asthma.

Authors:  D Talini; F Novelli; E Bacci; F L Dente; M De Santis; A Di Franco; L Melosini; B Vagaggini; P L Paggiaro
Journal:  J Allergy (Cairo)       Date:  2011-05-25

9.  Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.

Authors:  Jeong-Hee Choi; Yu-Jin Suh; Soo-Keol Lee; Chang-Hee Suh; Dong-Ho Nahm; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

10.  Diisocyanate-induced asthma in Switzerland: long-term course and patients' self-assessment after a 12-year follow-up.

Authors:  Martin Rüegger; Doreen Droste; Markus Hofmann; Marcel Jost; David Miedinger
Journal:  J Occup Med Toxicol       Date:  2014-05-14       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.